Channing Der
University of North Carolina at Chapel Hill School of Medicine
16 papers found
Refreshing results…
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
UploadConcurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
UploadTumor-selective activity of RAS-GTP inhibition in pancreatic cancer
UploadRHOA L57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling
UploadTEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
UploadConvergence of Targeted and Immune Therapies for the Treatment of Oncogene-Driven Cancers
Download from aacrjournals.orgCombination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer
Download from aacrjournals.orgFunctional and biological heterogeneity of KRAS Q61 mutations
UploadCombination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Download from www.nature.comEvaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies
Download from europepmc.orgMissing publications? Search for publications with a matching author name.